{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T14:43:29Z","timestamp":1698504209640},"reference-count":37,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:00:00Z","timestamp":1146096000000},"content-version":"vor","delay-in-days":3099,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cutan Pathol"],"published-print":{"date-parts":[[1997,11]]},"abstract":"<jats:p>XMEL is a monoclonal antibody raised against part of the extracellular domain of the putative tyrosine kinase receptor protein implicated in the pathogenesis of melanoma formation in the <jats:italic>Xiphophorus<\/jats:italic> fish melanoma model. Our objective in this study was to determine the diagnostic and prognostic utility of XMEL for human melanoma. Formalin\u2010fixed tissue from 82 melanomas, 42 carcinomas, 23 neural tumors, 12 lymphomas and 12 sarcomas were immunostained with XMEL and compared with a widely used melanoma antibody, HMB\u201045. The sensitivity of HMB\u201045 (83.1%) was similar to that of XMEL (79.8%). XMEL detected 7 melanomas that were HMB\u201045 negative. Specificity for detection of melanoma was greater with HMB\u201045 (95.5%) as compared to XMEL (80.9%). Of interest, all 4 prostatic adenocarcinomas were XMEL positive. These data suggest that XMEL is as sensitive but not as specific as HMB\u201045 in the detection of cutaneous melanoma but may serve as an ancillary antibody to improve diagnostic yield. The consistent positivity of XMEL in melanoma lends support to the hypothesis that the detected protein plays a role in melanoma pathogenesis. XMEL reactivity is not an independent prognosticator of death from melanoma in 37 melanomas from patients with at least 10 years' follow\u2010up. These data and the fact that XMEL shows variable reactivity with metastatic melanomas but almost 100% reactivity with the primary melanomas suggest that the antigen recognized by the XMEL antibody may be important in the early stages of melanoma progression. This is supported by our earlier observation that XMEL is reactive with dysplastic nevi, a precursor of malignant melanoma.<\/jats:p>","DOI":"10.1111\/j.1600-0560.1997.tb01093.x","type":"journal-article","created":{"date-parts":[[2006,4,29]],"date-time":"2006-04-29T10:05:47Z","timestamp":1146305147000},"page":"620-627","source":"Crossref","is-referenced-by-count":6,"title":["The Xiphophorus\u2010derived antibody, XMEL, shows sensitivity and specificity for human cutaneous melanoma but is not a prognostic marker"],"prefix":"10.1111","volume":"24","author":[{"given":"J. R.","family":"Vielkind","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. A.","family":"Tron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)80487-5"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199107183250306"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(84)80310-X"},{"key":"e_1_2_1_5_2","first-page":"645","article-title":"Genetics of melanoma","volume":"9","author":"Fountain JW","year":"1990","journal-title":"Cancer Surv"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1439824"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.21.10557"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870120211"},{"key":"e_1_2_1_9_2","first-page":"3111","article-title":"Loss of heterozygosity for 10q22\u201010qter in malignant melanoma progression","volume":"54","author":"Herbst RA","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870080307"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(95)00057-V"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(84)90024-4"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/80.14.1159"},{"key":"e_1_2_1_14_2","first-page":"936","article-title":"Confirmation of chromosome 9p linkage in familial melanoma","volume":"53","author":"Nancarrow DJ","year":"1993","journal-title":"Am J Hum Genet"},{"key":"e_1_2_1_15_2","first-page":"537","article-title":"Further evidence for a locus for cutaneous malignant melanoma\u2010dysplastic nevus (CMM\/DN) on chromosome 1p and evidence for genetic heterogeneity","volume":"52","author":"Goldstein AM","year":"1993","journal-title":"Am J Hum Genet"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0994-15"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8153634"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0994-22"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0795-351"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1095-210"},{"key":"e_1_2_1_21_2","first-page":"2713","article-title":"Loss of expression of the pl6\/cyclin\u2010dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression","volume":"55","author":"Reed JA","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_1_22_2","first-page":"660","article-title":"Neoplasm studies. VII. Cell types in tissue culture of fish melanocytic tumors compared with mammalian melanomas","volume":"1","author":"Grand CG","year":"1941","journal-title":"Cancer Res"},{"key":"e_1_2_1_23_2","first-page":"171","article-title":"Tissue culture studies of pigmented melanomas: fish, mouse, and human. In: The Biology of Melanomas. (Spec Publ)","volume":"4","author":"Grand CG","year":"1948","journal-title":"NY Acad Sci"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/341415a0"},{"key":"e_1_2_1_25_2","first-page":"575","article-title":"Differences in transcription and promoters of XMRK\u20101 and XMRK\u20102 genes suggest a role for XMRK\u20102 in pigment pattern development in the platyfish Xiphophorus maculatus","volume":"5","author":"Woolcock BW","year":"1994","journal-title":"Cell Growth Differ"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/jez.1401960207"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1577\/1548-8667(1989)001<0069:GOMIXF>2.3.CO;2"},{"key":"e_1_2_1_28_2","first-page":"285","volume-title":"Tranformation of Human Epithelial Cells: Molecular and Oncogenetic Mechanisms","author":"Vielkind JR","year":"1992"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.23.13042"},{"key":"e_1_2_1_30_2","first-page":"656","article-title":"A putative marker for human melanoma \u2013 A monoclonal antibody derived from the melanoma gene of the Xiphophorus melanoma model","volume":"143","author":"Vielkind JR","year":"1993","journal-title":"Am J Pathol"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199706000-00004"},{"key":"e_1_2_1_32_2","first-page":"195","article-title":"Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes","volume":"123","author":"Gown AM","year":"1986","journal-title":"Am J Pathol"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197011000-00017"},{"key":"e_1_2_1_34_2","first-page":"76","article-title":"Immunohistochemistry in the evaluation of melanocytic tumours","volume":"10","author":"Ruiter DJ","year":"1993","journal-title":"Semin Diagn Pathol"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12616793"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1993.422"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910520207"},{"key":"e_1_2_1_38_2","first-page":"1759","article-title":"Intertumoral heterogeneity of receptor\u2010kinase expression in human melanoma cell lines with different metastatic capabilities","volume":"14","author":"Gutman M","year":"1994","journal-title":"Anticancer Res"}],"container-title":["Journal of Cutaneous Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0560.1997.tb01093.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0560.1997.tb01093.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:53:16Z","timestamp":1698414796000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0560.1997.tb01093.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["10.1111\/j.1600-0560.1997.tb01093.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0560.1997.tb01093.x","archive":["Portico"],"relation":{},"ISSN":["0303-6987","1600-0560"],"issn-type":[{"value":"0303-6987","type":"print"},{"value":"1600-0560","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}